Table 4

Multivariable adjusted RR of CRC mortality

MenWomenMen and women
RR95% CIRR95% CIRR95% CI
Model 1c
 PLG, mg/dl
  ≤1191.001.001.00
  120–1591.080.76–1.551.761.13–2.761.310.99–1.73
  160–1990.840.54–1.311.350.77–2.351.010.71–1.42
  ≥2001.480.93–2.351.941.04–3.601.641.13–2.37
P for trend0.260.080.05
 Quartiles of BMI, kg/m2
  Q11.001.001.00
  Q21.080.68–1.710.920.50–1.661.020.71–1.47
  Q31.310.85–2.021.090.63–1.901.240.88–1.75
  Q41.420.92–2.190.910.52–1.611.220.87–1.72
P for trend0.070.760.22
 Heightb1.241.07–1.430.950.79–1.161.131.01–1.27
Model 2c
 Insulin resistance clustering: in the upper quartile of the distribution on PLG, SBP, BMI, or heart rate
  0 of 4 components1.001.001.00
  1 of 4 components1.000.66–1.521.120.69–1.811.050.76–1.44
  2 of 4 components1.531.00–2.341.220.72–2.071.391.00–1.93
  ≥3 of 4 components1.671.04–2.701.290.70–2.371.501.03–2.19
  • a Under Model 1, RR, adjusted for categories of age, race (African-American versus other), categories of education, and each of the other factors listed. Model for men and women combined includes a covariate for sex.

  • b RRs are for an increase of 7 cm in height.

  • c Under Model 2, RR, adjusted for categories of age, race (African-American versus other), categories of education, and height. Model for men and women combined includes a covariate for sex.